QL
XENE icon

Quarry LP’s Xenon Pharmaceuticals XENE Stock Holding History

Quarry LP’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,500
Closed -$100K – 2682
2025
Q3 		$100K Buy
2,500
+500
+25% +$17.6K 0.02% 539
2025
Q2 		$62.6K Hold
2,000
– – 0.01% 758
2025
Q1 		$67.1K Hold
2,000
– – 0.01% 676
2024
Q4 		$78.4K Buy
+2,000
New +$82.7K 0.01% 540
2024
Q3 		– Sell
-4,000
Closed -$156K – 2134
2024
Q2 		$156K Buy
4,000
+2,700
+208% +$108K 0.04% 215
2024
Q1 		$56K Buy
1,300
+300
+30% +$13.8K 0.01% 414
2023
Q4 		$46.1K Sell
1,000
-3,500
-78% -$124K 0.01% 355
2023
Q3 		$154K Buy
+4,500
New +$168K 0.04% 166

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Quarry LP's XENE Position: Q4 2025 in Review

Quarry LP sold out of Xenon Pharmaceuticals (XENE) in Q4 2025, closing a stake of 2,500 shares — an estimated $100K sold.

Quarry LP first reported a position in XENE in Q3 2023 and held it in 8 quarters. The position peaked at $156K in Q2 2024. 245 funds tracked by Wall St. Rank hold XENE as of Q4 2025.

  • Quarry LP reported no remaining Xenon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Quarry LP sold 2,500 Xenon Pharmaceuticals shares in Q4 2025, an estimated $100K.
  • Quarry LP first reported a position in Xenon Pharmaceuticals in Q3 2023 and held it in 8 quarters.
  • Quarry LP's Xenon Pharmaceuticals position peaked at $156K in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.